IL6R and neoplasm: In addition, IL-6 was detected in MDCS (Fig. 3c), and the IL-6R-neutralizing antibody inhibited both STAT3 activation and tumor proliferation induced by MDCS stimulation in both tumor cell lines (Fig. 3d and e).